SCHEMBL22699129

SCHEMBL22699129

Cc1ccc(C(=O)Nc2ccc(CN3CCCC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1

nearest known ligand 0.90

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 16/20 0.90
▸ FGFR1 P11362 2/20 0.90
▸ CYP2C9 P11712 1/20 0.90
▸ PDGFRA P16234 1/20 0.90
▸ CYP2C19 P33261 1/20 0.90
▸ FLT3 P36888 1/20 0.90
▸ LRRK2 Q5S007 1/20 0.90
▸ HDAC6 Q9UBN7 1/20 0.90
▸ KIT P10721 3/20 0.71
▸ KDR P35968 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Olverembatinib SCHEMBL29387193 0.95 ABL1 (1.00) ABL1FGFR1CYP2C9PDGFRACYP2C19
Olverembatinib SCHEMBL3424528 0.95 ABL1 (1.00) ABL1FGFR1CYP2C9PDGFRACYP2C19
Olverembatinib SCHEMBL29514988 0.95 ABL1 (1.00) ABL1FGFR1CYP2C9PDGFRACYP2C19
Olverembatinib SCHEMBL30456095 0.94 ABL1 (0.99) ABL1FGFR1CYP2C9PDGFRACYP2C19
Olverembatinib SCHEMBL29515011 0.94 ABL1 (0.99) ABL1FGFR1CYP2C9PDGFRACYP2C19
SCHEMBL26910782 0.94 ABL1 (0.88) ABL1FGFR1CYP2C9PDGFRACYP2C19
Olverembatinib SCHEMBL14953130 0.94 ABL1 (0.99) ABL1FGFR1CYP2C9PDGFRACYP2C19
SCHEMBL24340587 0.94 ABL1 (0.89) ABL1FGFR1CYP2C9PDGFRACYP2C19
Olverembatinib SCHEMBL29652687 0.92 ABL1 (0.94) ABL1FGFR1CYP2C9PDGFRACYP2C19
Olverembatinib SCHEMBL14953403 0.92 ABL1 (0.94) ABL1FGFR1CYP2C9PDGFRACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3741751-A1 HETEROCYCLIC ALKYNYL BENZENE COMPOUNDS AND MEDICAL COMPOSITIONS AND USES THEREOF Guangzhou Healthquest Pharma Co., Ltd. (CN) 2020-11-25 — — EP disclosed
Send feedback